Hum Mol Genet. 2011 Dec 1;20(23):4732-47. doi: 10.1093/hmg/ddr388. Epub 2011 Sep 2.
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Cox DG,
Simard J,
Sinnett D,
Hamdi Y,
Soucy P,
Ouimet M,
Barjhoux L,
Verny-Pierre C,
McGuffog L,
Healey S,
Szabo C,
Greene MH,
Mai PL,
Andrulis IL;
Ontario Cancer Genetics Network,
Thomassen M,
Gerdes AM,
Caligo MA,
Friedman E,
Laitman Y,
Kaufman B,
Paluch SS,
Borg Å,
Karlsson P,
Askmalm MS,
Bustinza GB;
SWE-BRCA Collaborators,
Nathanson KL,
Domchek SM,
Rebbeck TR,
Benítez J,
Hamann U,
Rookus MA,
van den Ouweland AM,
Ausems MG,
Aalfs CM,
van Asperen CJ,
Devilee P,
Gille HJ;
HEBON;
EMBRACE,
Peock S,
Frost D,
Evans DG,
Eeles R,
Izatt L,
Adlard J,
Paterson J,
Eason J,
Godwin AK,
Remon MA,
Moncoutier V,
Gauthier-Villars M,
Lasset C,
Giraud S,
Hardouin A,
Berthet P,
Sobol H,
Eisinger F,
Bressac de Paillerets B,
Caron O,
Delnatte C;
GEMO Study Collaborators,
Goldgar D,
Miron A,
Ozcelik H,
Buys S,
Southey MC,
Terry MB;
Breast Cancer Family Registry,
Singer CF,
Dressler AC,
Tea MK,
Hansen TV,
Johannsson O,
Piedmonte M,
Rodriguez GC,
Basil JB,
Blank S,
Toland AE,
Montagna M,
Isaacs C,
Blanco I,
Gayther SA,
Moysich KB,
Schmutzler RK,
Wappenschmidt B,
Engel C,
Meindl A,
Ditsch N,
Arnold N,
Niederacher D,
Sutter C,
Gadzicki D,
Fiebig B,
Caldes T,
Laframboise R,
Nevanlinna H,
Chen X,
Beesley J,
Spurdle AB,
Neuhausen SL,
Ding YC,
Couch FJ,
Wang X,
Peterlongo P,
Manoukian S,
Bernard L,
Radice P,
Easton DF,
Chenevix-Trench G,
Antoniou AC,
Stoppa-Lyonnet D,
Mazoyer S,
Sinilnikova OM;
Consortium of Investigators of Modifiers of BRCA1/2.
Glendon G, Selander T, Weerasooriya N, Karlsson P, Nordling M, Bergman A, Einbeigi Z, Stenmark-Askmalm M, Liedgren S, Borg Å, Loman N, Olsson H, Kristoffersson U, Soller M, Jernström H, Harbst K, Henriksson K, Lindblom A, Arver B, von Wachenfeldt A, Liljegren A, Barbany-Bustinza G, Rantala J, Melin B, Grönberg H, Stattin EL, Emanuelsson M, Ehrencrona H, Brandell RR, Dahl N, Hogervorst FB, Verhoef S, Verheus M, van't Veer LJ, van Leeuwen FE, Rookus MA, Collée M, van den Ouweland AM, Jager A, Hooning MJ, Tilanus-Linthorst MM, Seynaeve C, van Asperen CJ, Wijnen JT, Vreeswijk MP, Tollenaar RA, Devilee P, Ligtenberg MJ, Hoogerbrugge N, Ausems MG, van der Luijt RB, Aalfs CM, van Os TA, Gille JJ, Waisfisz Q, Meijers-Heijboer HE, Gomez-Garcia EB, van Roozendaal CE, Blok MJ, Caanen B, Oosterwijk JC, van der Hout AH, Mourits MJ, Vasen HF, Easton DF, Peock S, Cook M, Frost D, Platte R, Miedzybrodzka Z, Gregory H, Morrison P, Jeffers L, Cole T, Ong KR, Hoffman J, Donaldson A, James M, Paterson J, Downing S, Taylor A, Murray A, Rogers MT, McCann E, Kennedy MJ, Barton D, Porteous M, Drummond S, Brewer C, Kivuva E, Searle A, Goodman S, Hill K, Davidson R, Murday V, Bradshaw N, Snadden L, Longmuir M, Watt C, Gibson S, Haque E, Tobias E, Duncan A, Izatt L, Jacobs C, Langman C, Whaite A, Dorkins H, Barwell J, Adlard J, Chu C, Miller J, Ellis I, Houghton C, Evans DG, Lalloo F, Taylor J, Side L, Male A, Berlin C, Eason J, Collier R, Douglas F, Claber O, Jobson I, Walker L, McLeod D, Halliday D, Durell S, Stayner B, Eeles R, Shanley S, Rahman N, Houlston R, Bancroft E, D'Mello L, Page E, Ardern-Jones A, Kohut K, Wiggins J, Castro E, Mitra A, Robertson L, Cook J, Quarrell O, Bardsley C, Hodgson S, Goff S, Brice G, Winchester L, Eddy C, Tripathi V, Attard V, Eccles D, Lucassen A, Crawford G, McBride D, Smalley S, Sinilnikova O, Barjhoux L, Verny-Pierre C, Giraud S, Léone M, Mazoyer S, Stoppa-Lyonnet D, Gauthier-Villars M, Buecher B, Houdayer C, Moncoutier V, Belotti M, Tirapo C, de Pauw A, Bressac-de-Paillerets B, Remenieras A, Byrde V, Caron O, Lenoir G, Bignon YJ, Uhrhammer N, Lasset C, Bonadona V, Hardouin A, Berthet P, Sobol H, Bourdon V, Noguchi T, Eisinger F, Coulet F, Colas C, Soubrier F, Coupier I, Pujol P, Peyrat JP, Fournier J, Révillion F, Vennin P, Adenis C, Rouleau E, Lidereau R, Demange L, Nogues C, Muller D, Fricker JP, Longy M, Sevenet N, Toulas C, Guimbaud R, Gladieff L, Feillel V, Leroux D, Dreyfus H, Rebischung C, Coron F, Faivre L, Prieur F, Lebrun M, Ferrer SF, Frénay M, Vénat-Bouvet L, Delnatte C, Mortemousque I, Lynch HT, Snyder CL.
Source
INSERM U1052, CNRS UMR5286, Université Lyon 1, Cancer Research Center of Lyon, Lyon, France.
Abstract
Mutations in the BRCA1 gene substantially increase a woman's lifetime risk of breast cancer. However, there is great variation in this increase in risk with several genetic and non-genetic modifiers identified. The BRCA1 protein plays a central role in DNA repair, a mechanism that is particularly instrumental in safeguarding cells against tumorigenesis. We hypothesized that polymorphisms that alter the expression and/or function of BRCA1 carried on the wild-type (non-mutated) copy of the BRCA1 gene would modify the risk of breast cancer in carriers of BRCA1 mutations. A total of 9874 BRCA1 mutation carriers were available in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) for haplotype analyses of BRCA1. Women carrying the rare allele of single nucleotide polymorphism rs16942 on the wild-type copy of BRCA1 were at decreased risk of breast cancer (hazard ratio 0.86, 95% confidence interval 0.77-0.95, P = 0.003). Promoter in vitro assays of the major BRCA1 haplotypes showed that common polymorphisms in the regulatory region alter its activity and that this effect may be attributed to the differential binding affinity of nuclear proteins. In conclusion, variants on the wild-type copy of BRCA1 modify risk of breast cancer among carriers of BRCA1 mutations, possibly by altering the efficiency of BRCA1 transcription.
- PMID:
- 21890493
- [PubMed - indexed for MEDLINE]
-
Free full textPublication Types
MeSH Terms
Substances
Grant Support